Relyvrio's promise in ALS treatment highlights the importance of patient advocacy for deadly diseases.
it can be the alternative for people who do not want to perform the coloscopy — is being designed for people who have no symptoms of colon cancer and don’t belong to the high-risk group. as reported by HealthDay.